Immutep Limited
PRRUF
$0.20
-$0.004-1.96%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 3.22M | 2.88M | 2.52M | 2.56M | 2.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.22M | 2.88M | 2.52M | 2.56M | 2.61M |
| Cost of Revenue | 30.64M | 29.04M | 27.25M | 26.06M | 25.03M |
| Gross Profit | -27.42M | -26.16M | -24.73M | -23.51M | -22.42M |
| SG&A Expenses | 5.46M | 5.65M | 5.80M | 5.99M | 6.21M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.10M | 34.69M | 33.05M | 32.05M | 31.24M |
| Operating Income | -32.88M | -31.81M | -30.53M | -29.50M | -28.63M |
| Income Before Tax | -28.93M | -28.56M | -28.01M | -27.37M | -26.89M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -28.93 | -28.56 | -28.01 | -27.37 | -26.89 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.93M | -28.56M | -28.01M | -27.37M | -26.89M |
| EBIT | -32.88M | -31.81M | -30.53M | -29.50M | -28.63M |
| EBITDA | -32.23M | -30.86M | -29.29M | -28.27M | -27.40M |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 5.34B | 5.07B | 4.80B | 4.50B | 4.19B |
| Average Diluted Shares Outstanding | 5.34B | 5.07B | 4.80B | 4.50B | 4.19B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
